Best Practices for the Management of Non-Small Cell Lung Cancer

Micrograh of small cell carcinoma or also know as small cell lung cancer or oat-call carcinoma is a type of highly malignant cancer. PAP Stain

Program Overview This CME/CNE activity will review recent advances in patients with non-small cell lung cancer (NSCLC) incorporating data presented at the European Society For Medical Oncology (ESMO) 2018 Conference in Munich, Germany. The three expert faculty will analyze clinical trial data on the current science and emerging best practices for the treatment of NSCLC. The […]

Continue reading

The Increasing Role of Biosimilars in Oncology

3d render of immune system T cells attacking cancer cells (CAR T-cell therapy)

Program Overview This continuing education activity will focus on recent clinical trial data as well as therapeutic advances in the increasing role of biosimilars in oncology. The three expert faculty will review the fundamentals of biosimilars in oncology, including bioequivalence, totality of evidence, and interchangeability. A review of current clinical trial data of biosimilars for […]

Continue reading

The Role of Novel Therapeutics for the Treatment of Metastatic Colorectal Cancer

Microscopic photograph of a professionally prepared slide demonstrating lymph node with metastatic colonic adenocarcinoma. H&E stain.

Program Overview This continuing education activity will focus on recent clinical trial data and scientific advances in the treatment and management of patients with metastatic colorectal cancer as presented at the 2018 Gastrointestinal Cancers Symposium held in San Francisco, California. Three expert faculty will review the science of colorectal cancer, including patient screening guidelines and […]

Continue reading

A Clinical Analysis of Optimal Therapeutics to Improve Outcomes in Patients with Advanced Prostate Cancer


Program Overview This CE program will analyze optimal therapeutics for the treatment and management of prostate cancer patients, incorporating data presented at the American Society of Clinical Oncology 2018 Genitourinary (GU) Cancers Symposium in San Francisco, California. The three expert faculty, led by Dr. Elisabeth Heath, will review the framework for clinical decision making in […]

Continue reading